L. Xing

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.

R. Tibshirani, R. Advani, D. Czerwinski, 2012, Blood.

Persistent while declined neutralizing antibody responses in the convalescents of COVID-19 across clinical spectrum during the 16 months follow up

Yan Peng, F. Wang, Y. Liu, 2021, medRxiv.

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

R. Tibshirani, Y. Natkunam, R. Advani, 2010 .